ArticleFrontiers in neurology2025
Application of algorithms based on improved YOLO in MRI image detection of brain tumors.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Brain tumor detection on magnetic resonance imaging scans using the artificial intelligence-based You Only Look Once algorithm.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumors, characterized by irregular cell growth in the brain or surrounding tissues, encompass aggressive types like glioblastoma and more indolent forms such as meningiomas and pituitary tumors, often leading to increased intracranial pressure, neurological dysfunction, and low survival rates despite multimodal treatment. Early and precise identification of tumor subtypes in MRI images remains challenging due to image noise, heterogeneity, and morphological variability, limiting real-time clinical diagnostics. To address these issues, we propose an improved YOLO11n model for brain tumor detection, incorporating lightweight GhostConv modules for reduced redundancy, Online Convolutional Reparameterization (OREPA) in the C3k2 module for enhanced efficiency, and Efficient Multi-scale Attention (EMA) for better multiscale feature capture. Using 4,000 annotated MRI images from a public Kaggle dataset (glioma, meningioma, pituitary tumor, and no tumor), divided into training, validation, and test sets (8:1:1 ratio), the model was trained over 200 epochs and evaluated on internal and external sets. The optimized model achieved a mean average precision (mAP@50) of 97.2% and recall of 93.8%, surpassing the baseline YOLO11n by 2.1% in mAP@50 while reducing GFLOPS by 25% from 6.4 to 4.8, demonstrating superior accuracy, efficiency, and lightweight design for edge deployment. This approach not only facilitates rapid tumor localization and classification in clinical practice but also supports personalized treatment planning, offering extensible solutions for broader medical imaging applications and improved patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.